New cell movement process key to understanding and repairing facial malformations

October 18, 2018

The embryonic stem cells that form facial features, called neural crest cells, use an unexpected mechanism of moving from the back of the head to the front to populate the face, finds a new UCL-led study.

The researchers say their findings could help understand how facial defects form, bringing scientists one step closer to repairing craniofacial malformations in the embryo.

The new study, published in Science, reports a new and surprising mechanism that is likely to be important for other processes involving cell movement, such as cancer invasion during metastasis or wound healing, which may pave the way to develop new forms of therapies for each.

"Our findings solve a long-standing question in the scientific community about how cells move. The traditional explanation likens the process to how a train moves: there is an engine at the front of the train that generates the force, pulling the rest of the train forward. Our surprising discovery shows that the engine moving the cells is at the back and not at the front," said the study's lead author, Professor Roberto Mayor (UCL Cell & Developmental Biology).

This has important consequences as any new therapies based on modifying cell movement to repair facial malformation, improve wound healing or inhibit cancer metastasis should target the back cells, and not the front cells as traditionally done.

"In the womb, neural crest cells need to migrate from the back to the front of the head in order to form the face. For the first time, we've identified how that migration happens, and it appears to be similar to how you would squeeze toothpaste from the back of a tube to move the contents at the front," said Professor Mayor.

The discovery has important implications for understanding the causes of facial defects, such as cleft palate and facial palsy, which account for a third of all birth defects globally (3.2 million each year) and are the primary cause of infant mortality*.

For the study, the researchers investigated embryos of both frogs and fish, because their neural crest cells behave in a similar way to those of humans and their movement is often used to study the spread of cancer. In addition, the embryo development of frogs and fish can be studied without inflicting harm.

The team used light to control the behaviour of the neural crest cell cluster using a technique called optogenetics. After identifying a protein cable surrounding the cluster that contracts to move the cluster, they found that when neural crest cells at the back of the embryo were illuminated with a laser beam, they contracted and led to movement towards the face.

"By clarifying how faces develop, we can begin to investigate how that process can occur incompletely or differently to cause facial defects, and hopefully identify ways to prevent such harmful defects," said PhD researcher Adam Shellard (UCL Cell & Developmental Biology), a co-author of the paper.
-end-
The study was conducted by researchers at UCL and the Barcelona Institute of Science and Technology, and was funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council and Wellcome.

University College London

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.